Vienna - Delayed Quote EUR
Hologic, Inc. (HOLX.VI)
51.50
0.00
(0.00%)
At close: April 29 at 5:32:14 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 15 | 13 | 19 | 19 |
| Avg. Estimate | 1B | 1.03B | 4.08B | 4.3B |
| Low Estimate | 994.93M | 1.02B | 4.05B | 4.22B |
| High Estimate | 1B | 1.04B | 4.18B | 4.39B |
| Year Ago Sales | 1.02B | 1.01B | 4.03B | 4.08B |
| Sales Growth (year/est) | -1.71% | 1.37% | 1.31% | 5.38% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| HOLX.VI | -- | -- | -- | -- |
| S&P 500 | 9.62% | 4.20% | 8.36% | 13.90% |
Upgrades & Downgrades
| Maintains | Citigroup: Neutral to Neutral | 3/4/2025 |
| Reiterates | Raymond James: Outperform to Outperform | 2/6/2025 |
| Maintains | RBC Capital: Sector Perform to Sector Perform | 2/6/2025 |
| Maintains | Evercore ISI Group: In-Line to In-Line | 2/6/2025 |
| Reiterates | Stephens & Co.: Overweight to Overweight | 2/6/2025 |
| Downgrade | Leerink Partners: Outperform to Market Perform | 2/6/2025 |